Breaking News Instant updates and real-time market news.

OVID

Ovid Therapeutics

$6.19

-3.36 (-35.18%)

15:12
08/06/18
08/06
15:12
08/06/18
15:12

Ovid Therapeutics shares should recover from here, says Piper Jaffray

Piper Jaffray analyst Tyler Van Buren attributes Ovid Therapeutics' selloff to the lack of statistical significance on the domain-based endpoints in the Phase 2 STARS trial, but he believes the shares will recover from these levels as appreciation for the just-reported data grows and as the report of OV935 proof of concept dEE data near year-end approaches. The analyst, who thinks the dEE data has "exciting potential," keeps an Overweight rating and $20 price target on Ovid shares, which are down 35% to $6.20 in afternoon trading.

  • 06

    Aug

OVID Ovid Therapeutics
$6.19

-3.36 (-35.18%)

03/09/18
03/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Corcept Therapeutics (CORT) initiated with a Buy at B. Riley FBR. 2. Masimo (MASI) initiated with an Overweight at Barclays. 3. Ovid Therapeutics (OVID) initiated with an Overweight at Piper Jaffray. 4. Endocyte (ECYT) initiated with an Outperform at Wells Fargo. 5. Cloudera (CLDR) initiated with a Neutral at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/18
SBSH
04/03/18
NO CHANGE
Target $21
SBSH
Buy
Ovid Therapeutics data readouts should 'revitalize' shares, says Citi
OV101 data in Angelman syndrome and OV935 data in rare epilepsies should drive shares of Ovid Therapeutics in the second half of 2018, Citi analyst Yigal Nochomovitz tells investors in a research note. The stock has suffered from a lack of catalysts since the May 2017 initial public offering, but the two key proof-of-concept readouts expected later this year "should revitalize the story," the analyst contends. He keeps a Buy rating on Ovid Therapeutics with a $21 price target.
04/20/18
LTCO
04/20/18
INITIATION
Target $27
LTCO
Buy
Ovid Therapeutics initiated with a Buy at Ladenburg
Ladenburg analyst Michael Higgins initiated Ovid Therapeutics with a Buy and $27 price target.
05/18/18
PIPR
05/18/18
INITIATION
Target $20
PIPR
Overweight
Ovid Therapeutics assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren assumed coverage of Ovid Therapeutics with an Overweight rating and $20 price target. The company is enrolling genetically-defined orphan populations with preclinical models that have demonstrated encouraging results, Van Buren tells investors in a research note.

TODAY'S FREE FLY STORIES

YUM

Yum! Brands

$99.21

-1.04 (-1.04%)

07:29
03/20/19
03/20
07:29
03/20/19
07:29
Downgrade
Yum! Brands rating change  »

Yum! Brands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

DLTR

Dollar Tree

$101.29

0.28 (0.28%)

07:28
03/20/19
03/20
07:28
03/20/19
07:28
Initiation
Dollar Tree initiated  »

Dollar Tree initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$117.20

0.67 (0.57%)

07:27
03/20/19
03/20
07:27
03/20/19
07:27
Initiation
Dollar General initiated  »

Dollar General initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

, UPS

UPS

$110.37

-0.31 (-0.28%)

07:26
03/20/19
03/20
07:26
03/20/19
07:26
Downgrade
FedEx, UPS rating change  »

FedEx downgraded to…

FDX

FedEx

$181.50

-0.92 (-0.50%)

UPS

UPS

$110.37

-0.31 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Apr

  • 25

    Jun

COST

Costco

$237.05

0.43 (0.18%)

07:25
03/20/19
03/20
07:25
03/20/19
07:25
Initiation
Costco initiated  »

Costco initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 30

    May

DOMO

Domo

$43.96

0.68 (1.57%)

07:25
03/20/19
03/20
07:25
03/20/19
07:25
Conference/Events
Domo to host financial analyst and investor meeting »

Financial analyst and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 10

    Apr

ALXN

Alexion

$132.94

-0.53 (-0.40%)

07:25
03/20/19
03/20
07:25
03/20/19
07:25
Conference/Events
Alexion to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Jun

BJ

BJ's Wholesale

$25.71

0.015 (0.06%)

07:24
03/20/19
03/20
07:24
03/20/19
07:24
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$6.40

0.13 (2.07%)

07:23
03/20/19
03/20
07:23
03/20/19
07:23
Recommendations
Aurinia Pharmaceuticals analyst commentary  »

Aurinia Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

07:23
03/20/19
03/20
07:23
03/20/19
07:23
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

AMZN

Amazon.com

$1,762.45

20.45 (1.17%)

07:22
03/20/19
03/20
07:22
03/20/19
07:22
Initiation
Amazon.com initiated  »

Amazon.com initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

SSP

E.W. Scripps

$22.47

0.05 (0.22%)

, NXST

Nexstar

$105.71

-0.85 (-0.80%)

07:21
03/20/19
03/20
07:21
03/20/19
07:21
Conference/Events
E.W. Scripps to host conference call »

Conference call to…

SSP

E.W. Scripps

$22.47

0.05 (0.22%)

NXST

Nexstar

$105.71

-0.85 (-0.80%)

TRCO

Tribune Media

$46.08

0.02 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVDA

Nvidia

$175.77

6.86 (4.06%)

07:20
03/20/19
03/20
07:20
03/20/19
07:20
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$41.48

-1.61 (-3.74%)

07:18
03/20/19
03/20
07:18
03/20/19
07:18
Recommendations
HD Supply analyst commentary  »

HD Supply price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

NOW

ServiceNow

$241.93

0.74 (0.31%)

07:18
03/20/19
03/20
07:18
03/20/19
07:18
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

07:17
03/20/19
03/20
07:17
03/20/19
07:17
Recommendations
FedEx analyst commentary at KeyBanc »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

FTK

Flotek

$3.28

-0.07 (-2.09%)

07:17
03/20/19
03/20
07:17
03/20/19
07:17
Hot Stocks
Flotek to separate role of Chairman, CEO »

Flotek announced that as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$181.50

-0.92 (-0.50%)

07:16
03/20/19
03/20
07:16
03/20/19
07:16
Recommendations
FedEx analyst commentary at Deutsche Bank »

Deutsche defends FedEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 02

    Apr

  • 25

    Jun

WP

Worldpay

$107.39

-1.13 (-1.04%)

, FIS

FIS

$106.60

-1.54 (-1.42%)

07:16
03/20/19
03/20
07:16
03/20/19
07:16
Downgrade
Worldpay, FIS, Fiserv, First Data, Global Payments rating change  »

Worldpay downgraded to…

WP

Worldpay

$107.39

-1.13 (-1.04%)

FIS

FIS

$106.60

-1.54 (-1.42%)

FISV

Fiserv

$84.50

-0.59 (-0.69%)

FDC

First Data

$25.10

-0.26 (-1.03%)

GPN

Global Payments

$134.33

0.33 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

  • 25

    Apr

CAL

Caleres

$25.84

-1.3 (-4.79%)

, EMR

Emerson

$68.45

-0.32 (-0.47%)

07:13
03/20/19
03/20
07:13
03/20/19
07:13
Hot Stocks
Caleres elects Emerson CCO Lisa Flavin to board of directors »

Caleres (CAL) announced…

CAL

Caleres

$25.84

-1.3 (-4.79%)

EMR

Emerson

$68.45

-0.32 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 07

    May

SMAR

Smartsheet

$43.51

-0.16 (-0.37%)

07:12
03/20/19
03/20
07:12
03/20/19
07:12
Recommendations
Smartsheet analyst commentary  »

Smartsheet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Apr

SSP

E.W. Scripps

$22.47

0.05 (0.22%)

, NXST

Nexstar

$105.71

-0.85 (-0.80%)

07:12
03/20/19
03/20
07:12
03/20/19
07:12
Hot Stocks
E.W. Scripps acquiring eight TV stations from Nexstar-Tribune merger divestiture »

E.W. Scripps (SSP) is…

SSP

E.W. Scripps

$22.47

0.05 (0.22%)

NXST

Nexstar

$105.71

-0.85 (-0.80%)

TRCO

Tribune Media

$46.08

0.02 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$144.95

0.61 (0.42%)

07:11
03/20/19
03/20
07:11
03/20/19
07:11
Recommendations
Lululemon analyst commentary  »

Barclays remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

GIS

General Mills

$47.24

-0.365 (-0.77%)

07:11
03/20/19
03/20
07:11
03/20/19
07:11
Hot Stocks
Breaking Hot Stocks news story on General Mills »

General Mills up 6.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

ALXN

Alexion

$132.94

-0.53 (-0.40%)

, ZEAL

Zealand Pharma

$15.60

(0.00%)

07:11
03/20/19
03/20
07:11
03/20/19
07:11
Hot Stocks
Alexion, Zealand Pharma announce collaboration for peptide therapies »

Alexion Pharmaceuticals…

ALXN

Alexion

$132.94

-0.53 (-0.40%)

ZEAL

Zealand Pharma

$15.60

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.